Prostate cancer is a health issue that impacts individuals worldwide, and choosing the best treatment can be difficult, given ...

Prostate cancer ranks among the most common health challenges men face worldwide. While medical advances continue to improve treatment outcomes, the e ...

Oral estrogens were the treatment of choice for carcinoma of the prostate ... a short-term but modest increase in cardiovascular morbidity (but not mortality) is compensated for by a long-term ...

MRI-Guided Radiation Therapy Reduces Long-Term Side Effects for Patients ... in treating biochemically recurrent prostate cancer without accompanying hormone therapy for men who have mutations ...

Recently, licensed and emerging treatments for metastatic castrate-resistant prostate cancer are transforming ... for which the focus of treatment should be to enable patients to live as near ...

Sleep apnoea is a sleep disorder that causes a person to repeatedly stop or shallowly breathe while sleeping Read this ...

“Our findings highlight the coordinated interplay between GCN2 and p53 regulation during nutrient stress and provide insight into how they could be targeted in developing new therapeutic strategies ...

Advanced Imaging Uncovers Hidden Metastases in High-Risk Prostate Cancer Cases Jan. 3, 2025 — A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer ...

As with many cancers, early treatment is associated with not only better outcomes but a reduction in treatment-related side effects. Prostate cancer is the second most common cancer in men in the U.S.

Darolutamide + ADT in combination with docetaxel is to be used to treat patients with metastatic hormone-sensitive prostate cancer ... but long waiting times for treatment threaten to undermine ...

Testicular atrophy means the testes inside the scrotum ("ball sack") shrink. It is a treatable medical condition. Learn how ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...